Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas. A home-based palliative care program was ...

Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality.

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

The survey was conducted in May 2025 online (978 participants) and by telephone (30 participants).

Obinutuzumab, a B-cell depleting therapy, is being explored for reducing lupus nephritis risks, such as flare.

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

Childhood cancer survivors have a higher risk of developing severe COVID-19 than the general population, data suggest.

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

Robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty is feasible, with acceptable complication rates.

An estimated 3 out of 10 people using cannabis have a cannabis-related disorder, which suggests many are at risk for any adverse health effects.